Gastric inflammatory markers and interleukins in patients with functional dyspepsia treated with astaxanthin
The chronic active inflammation caused by Helicobacter pylori is dominated by neutrophils, macrophages, lymphocytes and plasma cells. Several interleukins are involved in the inflammatory process. The aim of this study was to investigate the effect of astaxanthin on gastric inflammation in patients...
Gespeichert in:
| Veröffentlicht in: | FEMS immunology and medical microbiology 2007-07, Vol.50 (2), p.244-248 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 248 |
|---|---|
| container_issue | 2 |
| container_start_page | 244 |
| container_title | FEMS immunology and medical microbiology |
| container_volume | 50 |
| creator | Andersen, Leif Percival Holck, Susanne Kupcinskas, Limas Kiudelis, Gediminas Jonaitis, Laimas Janciauskas, Dainius Permin, Henrik Wadström, Torkel |
| description | The chronic active inflammation caused by Helicobacter pylori is dominated by neutrophils, macrophages, lymphocytes and plasma cells. Several interleukins are involved in the inflammatory process. The aim of this study was to investigate the effect of astaxanthin on gastric inflammation in patients with functional dyspepsia. Forty-four consecutive patients were included, and biopsies were examined for IL-4, IL-6, IL-8, IL-10, interferon-γ, CD4, CD8, CD14, CD19, CD25 and CD30. Patients were randomized: 21 patients were treated with 40 mg of astaxanthin daily, and 23 patients were treated with a placebo. There was a significant decrease in gastric inflammation in H. pylori-positive patients from both groups. There were no significant changes in the density of H. pylori or in any of the interleukins during or after treatment. There was a significant up-regulation of CD4 and down-regulation of CD8 in patients with H. pylori treated with astaxanthin. Astaxanthin had an effect on the inflammation and on the density of H. pylori in mice in a study where the diet could be standardized without antioxidants ( Bennedsen et al., 1999 ). These dietary conditions are impossible in studies involving humans, and may be due to the minor effect when the host have access to antioxidants in their diet. |
| doi_str_mv | 10.1111/j.1574-695X.2007.00257.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_proquest_miscellaneous_70616357</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1111/j.1574-695X.2007.00257.x</oup_id><sourcerecordid>20425490</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6427-b32d9cbed0029abda5cb0afa6cc1b68efeb20e157bd9654db657988bac4ebfa63</originalsourceid><addsrcrecordid>eNqNkt-L1DAQx4t4eOvpv6AF0beuadImKfgih3ce7OGDHvgWJunUy163rUnL7v73zl6XO5ADDQxhyOc7mV9JkuZsmdP5uF7mpSoyWZU_l5wxtWSMl2q5e5YsHh6eJwtWcZ1pXhSnycsY14yxomLsRXKaq5LnouKLpL2EOAbvUt81LWw2MPZhn24g3GGIKXQ1PYwYWpzufBfJSQcYPXZjTLd-vE2bqXOj7zto03ofBxyih3QMCCPWM0HxYQfdeOu7V8lJA23E18f7LLm5-PLj_Gu2-nZ5df55lTlZcJVZwevKWaypqgpsDaWzDBqQzuVWamzQcoZUqK0rWRa1laWqtLbgCrSEibNkNceNWxwma4bgqaK96cGbdhrILJmJaIAVliGAcY1DUzSCmSq3wpCnhQSdCyUo3Ic53BD63xPG0Wx8dNi20GE_RaOYzKUo1T9Bzgpe0ggIfPcXuO6nQE0kRjDJlZQsJ0rPlAt9jAGbh0JyZg57YNbmMG5zGLc57IG53wOzI-mb4weT3WD9KDwOnoD3RwCig7YJ0DkfHzmttdLVIYdPM7f1Le7_OwFzcXXN7zsiZnlPbX9anD2V_dtZ1UBv4FegxG6-c-oIQVqUvBB_AJtq6gY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2306276601</pqid></control><display><type>article</type><title>Gastric inflammatory markers and interleukins in patients with functional dyspepsia treated with astaxanthin</title><source>MEDLINE</source><source>Wiley Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Andersen, Leif Percival ; Holck, Susanne ; Kupcinskas, Limas ; Kiudelis, Gediminas ; Jonaitis, Laimas ; Janciauskas, Dainius ; Permin, Henrik ; Wadström, Torkel</creator><creatorcontrib>Andersen, Leif Percival ; Holck, Susanne ; Kupcinskas, Limas ; Kiudelis, Gediminas ; Jonaitis, Laimas ; Janciauskas, Dainius ; Permin, Henrik ; Wadström, Torkel</creatorcontrib><description>The chronic active inflammation caused by Helicobacter pylori is dominated by neutrophils, macrophages, lymphocytes and plasma cells. Several interleukins are involved in the inflammatory process. The aim of this study was to investigate the effect of astaxanthin on gastric inflammation in patients with functional dyspepsia. Forty-four consecutive patients were included, and biopsies were examined for IL-4, IL-6, IL-8, IL-10, interferon-γ, CD4, CD8, CD14, CD19, CD25 and CD30. Patients were randomized: 21 patients were treated with 40 mg of astaxanthin daily, and 23 patients were treated with a placebo. There was a significant decrease in gastric inflammation in H. pylori-positive patients from both groups. There were no significant changes in the density of H. pylori or in any of the interleukins during or after treatment. There was a significant up-regulation of CD4 and down-regulation of CD8 in patients with H. pylori treated with astaxanthin. Astaxanthin had an effect on the inflammation and on the density of H. pylori in mice in a study where the diet could be standardized without antioxidants ( Bennedsen et al., 1999 ). These dietary conditions are impossible in studies involving humans, and may be due to the minor effect when the host have access to antioxidants in their diet.</description><identifier>ISSN: 0928-8244</identifier><identifier>ISSN: 2049-632X</identifier><identifier>EISSN: 1574-695X</identifier><identifier>EISSN: 2049-632X</identifier><identifier>DOI: 10.1111/j.1574-695X.2007.00257.x</identifier><identifier>PMID: 17521392</identifier><language>eng</language><publisher>Oxford, UK: Oxford, UK : Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Animals ; Anti-Inflammatory Agents, Non-Steroidal - administration & dosage ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Antigens, CD - analysis ; Antioxidants ; Astaxanthin ; Basic Medicine ; Biological and medical sciences ; Biomarkers - analysis ; Biopsy ; CD14 antigen ; CD19 antigen ; CD25 antigen ; CD30 antigen ; CD4 ; CD4 antigen ; CD8 ; CD8 antigen ; Colony Count, Microbial ; Cytokines - analysis ; Density ; Diet ; Disease Models, Animal ; Dyspepsia ; Dyspepsia - drug therapy ; Female ; Fundamental and applied biological sciences. Psychology ; gastric inflammation ; gastritis ; Helicobacter Infections - drug therapy ; Helicobacter pylori ; Humans ; Inflammation ; Interferon ; Interleukin 10 ; Interleukin 4 ; Interleukin 6 ; Interleukin 8 ; interleukins ; Leukocytes (neutrophilic) ; Lymphocytes ; Macrophages ; Male ; Medical and Health Sciences ; Medicin och hälsovetenskap ; Medicinska och farmaceutiska grundvetenskaper ; Mice ; Microbiology ; Microbiology in the medical area ; Middle Aged ; Mikrobiologi inom det medicinska området ; Plasma cells ; Stomach - microbiology ; Stomach - pathology ; Xanthophylls - administration & dosage ; Xanthophylls - therapeutic use ; γ-Interferon</subject><ispartof>FEMS immunology and medical microbiology, 2007-07, Vol.50 (2), p.244-248</ispartof><rights>2007 Federation of European Microbiological Societies 2007</rights><rights>2007 INIST-CNRS</rights><rights>2007 Federation of European Microbiological Societies</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6427-b32d9cbed0029abda5cb0afa6cc1b68efeb20e157bd9654db657988bac4ebfa63</citedby><cites>FETCH-LOGICAL-c6427-b32d9cbed0029abda5cb0afa6cc1b68efeb20e157bd9654db657988bac4ebfa63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1574-695X.2007.00257.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1574-695X.2007.00257.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,885,1417,23930,23931,25140,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18887891$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17521392$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://lup.lub.lu.se/record/907754$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Andersen, Leif Percival</creatorcontrib><creatorcontrib>Holck, Susanne</creatorcontrib><creatorcontrib>Kupcinskas, Limas</creatorcontrib><creatorcontrib>Kiudelis, Gediminas</creatorcontrib><creatorcontrib>Jonaitis, Laimas</creatorcontrib><creatorcontrib>Janciauskas, Dainius</creatorcontrib><creatorcontrib>Permin, Henrik</creatorcontrib><creatorcontrib>Wadström, Torkel</creatorcontrib><title>Gastric inflammatory markers and interleukins in patients with functional dyspepsia treated with astaxanthin</title><title>FEMS immunology and medical microbiology</title><addtitle>FEMS Immunol Med Microbiol</addtitle><description>The chronic active inflammation caused by Helicobacter pylori is dominated by neutrophils, macrophages, lymphocytes and plasma cells. Several interleukins are involved in the inflammatory process. The aim of this study was to investigate the effect of astaxanthin on gastric inflammation in patients with functional dyspepsia. Forty-four consecutive patients were included, and biopsies were examined for IL-4, IL-6, IL-8, IL-10, interferon-γ, CD4, CD8, CD14, CD19, CD25 and CD30. Patients were randomized: 21 patients were treated with 40 mg of astaxanthin daily, and 23 patients were treated with a placebo. There was a significant decrease in gastric inflammation in H. pylori-positive patients from both groups. There were no significant changes in the density of H. pylori or in any of the interleukins during or after treatment. There was a significant up-regulation of CD4 and down-regulation of CD8 in patients with H. pylori treated with astaxanthin. Astaxanthin had an effect on the inflammation and on the density of H. pylori in mice in a study where the diet could be standardized without antioxidants ( Bennedsen et al., 1999 ). These dietary conditions are impossible in studies involving humans, and may be due to the minor effect when the host have access to antioxidants in their diet.</description><subject>Adult</subject><subject>Aged</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - administration & dosage</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Antigens, CD - analysis</subject><subject>Antioxidants</subject><subject>Astaxanthin</subject><subject>Basic Medicine</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - analysis</subject><subject>Biopsy</subject><subject>CD14 antigen</subject><subject>CD19 antigen</subject><subject>CD25 antigen</subject><subject>CD30 antigen</subject><subject>CD4</subject><subject>CD4 antigen</subject><subject>CD8</subject><subject>CD8 antigen</subject><subject>Colony Count, Microbial</subject><subject>Cytokines - analysis</subject><subject>Density</subject><subject>Diet</subject><subject>Disease Models, Animal</subject><subject>Dyspepsia</subject><subject>Dyspepsia - drug therapy</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>gastric inflammation</subject><subject>gastritis</subject><subject>Helicobacter Infections - drug therapy</subject><subject>Helicobacter pylori</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Interferon</subject><subject>Interleukin 10</subject><subject>Interleukin 4</subject><subject>Interleukin 6</subject><subject>Interleukin 8</subject><subject>interleukins</subject><subject>Leukocytes (neutrophilic)</subject><subject>Lymphocytes</subject><subject>Macrophages</subject><subject>Male</subject><subject>Medical and Health Sciences</subject><subject>Medicin och hälsovetenskap</subject><subject>Medicinska och farmaceutiska grundvetenskaper</subject><subject>Mice</subject><subject>Microbiology</subject><subject>Microbiology in the medical area</subject><subject>Middle Aged</subject><subject>Mikrobiologi inom det medicinska området</subject><subject>Plasma cells</subject><subject>Stomach - microbiology</subject><subject>Stomach - pathology</subject><subject>Xanthophylls - administration & dosage</subject><subject>Xanthophylls - therapeutic use</subject><subject>γ-Interferon</subject><issn>0928-8244</issn><issn>2049-632X</issn><issn>1574-695X</issn><issn>2049-632X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkt-L1DAQx4t4eOvpv6AF0beuadImKfgih3ce7OGDHvgWJunUy163rUnL7v73zl6XO5ADDQxhyOc7mV9JkuZsmdP5uF7mpSoyWZU_l5wxtWSMl2q5e5YsHh6eJwtWcZ1pXhSnycsY14yxomLsRXKaq5LnouKLpL2EOAbvUt81LWw2MPZhn24g3GGIKXQ1PYwYWpzufBfJSQcYPXZjTLd-vE2bqXOj7zto03ofBxyih3QMCCPWM0HxYQfdeOu7V8lJA23E18f7LLm5-PLj_Gu2-nZ5df55lTlZcJVZwevKWaypqgpsDaWzDBqQzuVWamzQcoZUqK0rWRa1laWqtLbgCrSEibNkNceNWxwma4bgqaK96cGbdhrILJmJaIAVliGAcY1DUzSCmSq3wpCnhQSdCyUo3Ic53BD63xPG0Wx8dNi20GE_RaOYzKUo1T9Bzgpe0ggIfPcXuO6nQE0kRjDJlZQsJ0rPlAt9jAGbh0JyZg57YNbmMG5zGLc57IG53wOzI-mb4weT3WD9KDwOnoD3RwCig7YJ0DkfHzmttdLVIYdPM7f1Le7_OwFzcXXN7zsiZnlPbX9anD2V_dtZ1UBv4FegxG6-c-oIQVqUvBB_AJtq6gY</recordid><startdate>200707</startdate><enddate>200707</enddate><creator>Andersen, Leif Percival</creator><creator>Holck, Susanne</creator><creator>Kupcinskas, Limas</creator><creator>Kiudelis, Gediminas</creator><creator>Jonaitis, Laimas</creator><creator>Janciauskas, Dainius</creator><creator>Permin, Henrik</creator><creator>Wadström, Torkel</creator><general>Oxford, UK : Blackwell Publishing Ltd</general><general>Blackwell Publishing Ltd</general><general>Blackwell</general><general>Oxford University Press</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7QL</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D95</scope></search><sort><creationdate>200707</creationdate><title>Gastric inflammatory markers and interleukins in patients with functional dyspepsia treated with astaxanthin</title><author>Andersen, Leif Percival ; Holck, Susanne ; Kupcinskas, Limas ; Kiudelis, Gediminas ; Jonaitis, Laimas ; Janciauskas, Dainius ; Permin, Henrik ; Wadström, Torkel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6427-b32d9cbed0029abda5cb0afa6cc1b68efeb20e157bd9654db657988bac4ebfa63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - administration & dosage</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Antigens, CD - analysis</topic><topic>Antioxidants</topic><topic>Astaxanthin</topic><topic>Basic Medicine</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - analysis</topic><topic>Biopsy</topic><topic>CD14 antigen</topic><topic>CD19 antigen</topic><topic>CD25 antigen</topic><topic>CD30 antigen</topic><topic>CD4</topic><topic>CD4 antigen</topic><topic>CD8</topic><topic>CD8 antigen</topic><topic>Colony Count, Microbial</topic><topic>Cytokines - analysis</topic><topic>Density</topic><topic>Diet</topic><topic>Disease Models, Animal</topic><topic>Dyspepsia</topic><topic>Dyspepsia - drug therapy</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>gastric inflammation</topic><topic>gastritis</topic><topic>Helicobacter Infections - drug therapy</topic><topic>Helicobacter pylori</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Interferon</topic><topic>Interleukin 10</topic><topic>Interleukin 4</topic><topic>Interleukin 6</topic><topic>Interleukin 8</topic><topic>interleukins</topic><topic>Leukocytes (neutrophilic)</topic><topic>Lymphocytes</topic><topic>Macrophages</topic><topic>Male</topic><topic>Medical and Health Sciences</topic><topic>Medicin och hälsovetenskap</topic><topic>Medicinska och farmaceutiska grundvetenskaper</topic><topic>Mice</topic><topic>Microbiology</topic><topic>Microbiology in the medical area</topic><topic>Middle Aged</topic><topic>Mikrobiologi inom det medicinska området</topic><topic>Plasma cells</topic><topic>Stomach - microbiology</topic><topic>Stomach - pathology</topic><topic>Xanthophylls - administration & dosage</topic><topic>Xanthophylls - therapeutic use</topic><topic>γ-Interferon</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Andersen, Leif Percival</creatorcontrib><creatorcontrib>Holck, Susanne</creatorcontrib><creatorcontrib>Kupcinskas, Limas</creatorcontrib><creatorcontrib>Kiudelis, Gediminas</creatorcontrib><creatorcontrib>Jonaitis, Laimas</creatorcontrib><creatorcontrib>Janciauskas, Dainius</creatorcontrib><creatorcontrib>Permin, Henrik</creatorcontrib><creatorcontrib>Wadström, Torkel</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Lunds universitet</collection><jtitle>FEMS immunology and medical microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Andersen, Leif Percival</au><au>Holck, Susanne</au><au>Kupcinskas, Limas</au><au>Kiudelis, Gediminas</au><au>Jonaitis, Laimas</au><au>Janciauskas, Dainius</au><au>Permin, Henrik</au><au>Wadström, Torkel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gastric inflammatory markers and interleukins in patients with functional dyspepsia treated with astaxanthin</atitle><jtitle>FEMS immunology and medical microbiology</jtitle><addtitle>FEMS Immunol Med Microbiol</addtitle><date>2007-07</date><risdate>2007</risdate><volume>50</volume><issue>2</issue><spage>244</spage><epage>248</epage><pages>244-248</pages><issn>0928-8244</issn><issn>2049-632X</issn><eissn>1574-695X</eissn><eissn>2049-632X</eissn><abstract>The chronic active inflammation caused by Helicobacter pylori is dominated by neutrophils, macrophages, lymphocytes and plasma cells. Several interleukins are involved in the inflammatory process. The aim of this study was to investigate the effect of astaxanthin on gastric inflammation in patients with functional dyspepsia. Forty-four consecutive patients were included, and biopsies were examined for IL-4, IL-6, IL-8, IL-10, interferon-γ, CD4, CD8, CD14, CD19, CD25 and CD30. Patients were randomized: 21 patients were treated with 40 mg of astaxanthin daily, and 23 patients were treated with a placebo. There was a significant decrease in gastric inflammation in H. pylori-positive patients from both groups. There were no significant changes in the density of H. pylori or in any of the interleukins during or after treatment. There was a significant up-regulation of CD4 and down-regulation of CD8 in patients with H. pylori treated with astaxanthin. Astaxanthin had an effect on the inflammation and on the density of H. pylori in mice in a study where the diet could be standardized without antioxidants ( Bennedsen et al., 1999 ). These dietary conditions are impossible in studies involving humans, and may be due to the minor effect when the host have access to antioxidants in their diet.</abstract><cop>Oxford, UK</cop><pub>Oxford, UK : Blackwell Publishing Ltd</pub><pmid>17521392</pmid><doi>10.1111/j.1574-695X.2007.00257.x</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0928-8244 |
| ispartof | FEMS immunology and medical microbiology, 2007-07, Vol.50 (2), p.244-248 |
| issn | 0928-8244 2049-632X 1574-695X 2049-632X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70616357 |
| source | MEDLINE; Wiley Journals; Oxford University Press Journals All Titles (1996-Current) |
| subjects | Adult Aged Animals Anti-Inflammatory Agents, Non-Steroidal - administration & dosage Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Antigens, CD - analysis Antioxidants Astaxanthin Basic Medicine Biological and medical sciences Biomarkers - analysis Biopsy CD14 antigen CD19 antigen CD25 antigen CD30 antigen CD4 CD4 antigen CD8 CD8 antigen Colony Count, Microbial Cytokines - analysis Density Diet Disease Models, Animal Dyspepsia Dyspepsia - drug therapy Female Fundamental and applied biological sciences. Psychology gastric inflammation gastritis Helicobacter Infections - drug therapy Helicobacter pylori Humans Inflammation Interferon Interleukin 10 Interleukin 4 Interleukin 6 Interleukin 8 interleukins Leukocytes (neutrophilic) Lymphocytes Macrophages Male Medical and Health Sciences Medicin och hälsovetenskap Medicinska och farmaceutiska grundvetenskaper Mice Microbiology Microbiology in the medical area Middle Aged Mikrobiologi inom det medicinska området Plasma cells Stomach - microbiology Stomach - pathology Xanthophylls - administration & dosage Xanthophylls - therapeutic use γ-Interferon |
| title | Gastric inflammatory markers and interleukins in patients with functional dyspepsia treated with astaxanthin |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T06%3A53%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gastric%20inflammatory%20markers%20and%20interleukins%20in%20patients%20with%20functional%20dyspepsia%20treated%20with%20astaxanthin&rft.jtitle=FEMS%20immunology%20and%20medical%20microbiology&rft.au=Andersen,%20Leif%20Percival&rft.date=2007-07&rft.volume=50&rft.issue=2&rft.spage=244&rft.epage=248&rft.pages=244-248&rft.issn=0928-8244&rft.eissn=1574-695X&rft_id=info:doi/10.1111/j.1574-695X.2007.00257.x&rft_dat=%3Cproquest_swepu%3E20425490%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2306276601&rft_id=info:pmid/17521392&rft_oup_id=10.1111/j.1574-695X.2007.00257.x&rfr_iscdi=true |